Polyclonal Antibody Therapies for Clostridium difficile Infection
Clostridium difficile infection has emerged as a growing worldwide health problem.The colitis of Clostridium difficile infection results from the synergistic action of C.difficile secreted toxins A and B upon the colon mucosa.A human monoclonal IgG anti-toxin has demonstrated the ability in combination therapy to reduce mortality in C.difficile cha